All lobbying filings

TIBER CREEK GROUP

Lobbying for PHRMA

Filing Q1 amendment

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Sep 30, 2025

Income

$110,000.00

What the client paid this registrant for the period.

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Medicare/Medicaid

Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Medicare Part D and Part B Pricing Reform.

Trade (domestic/foreign)

Issues related to intellectual property protections.

Health Issues

Issues related to the 340B Program - Public Health Service Act (PL 78-410).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.